Literature DB >> 1439156

Clinical application of IL6 in cancer therapy.

J J Mulé1, S G Marcus, J C Yang, J S Weber, S A Rosenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1439156     DOI： 10.1016/0923-2494(92)80023-e

Source DB:  PubMed          Journal:  Res Immunol        ISSN： 0923-2494


× No keyword cloud information.
  3 in total

1.  In vivo cytokine gene transfer by gene gun reduces tumor growth in mice.

Authors:  W H Sun; J K Burkholder; J Sun; J Culp; J Turner; X G Lu; T D Pugh; W B Ershler; N S Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

2.  Induction of lymphokine-activated killer activity in mice by prothymosin alpha.

Authors:  C N Baxevanis; A D Gritzapis; G V Dedoussis; N G Papadopoulos; O Tsolas; M Papamichail
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

3.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.